<?xml version="1.0" encoding="UTF-8"?>
<p>Apart from the above targets, other novel host-based targets, such as host glycosidase and novel iminosugar targets were also explored. For example, the two targets UV-4 and UV-5 have shown to reduce filovirus infections in vitro and in vivo, including DENV infection [
 <xref rid="B160-pharmaceuticals-12-00157" ref-type="bibr">160</xref>]. Therefore, these novel host-based targets have the potential for developing broad-spectrum antiviral drugs including anti-ZIKV drugs. In addition, bioinformatic approach generated from targets like siRNA [
 <xref rid="B144-pharmaceuticals-12-00157" ref-type="bibr">144</xref>] and interacting peptides [
 <xref rid="B147-pharmaceuticals-12-00157" ref-type="bibr">147</xref>] could be useful for ZIKV drug discovery.
</p>
